Virax Biolabs Group Limited Shareholder Meeting Summary

The 2025 Annual Meeting of Virax Biolabs Group Limited, initially scheduled for March 11, 2026, was adjourned due to a lack of quorum. The meeting reconvened on March 18, 2026, at which point a quorum was established. Shareholders approved several key proposals: the appointment of Reliant CPAs PC as auditor for the fiscal year ending March 31, 2026, the election of five director nominees, a share consolidation of ordinary shares on a 10-to-15 basis, the adoption of amended and restated memorandum and articles of association to reflect the share consolidation, and the 2026 Equity Incentive Plan. All proposals passed with a majority of shareholder votes.